ECSP034454A - Agente terapeutico cristalino - Google Patents

Agente terapeutico cristalino

Info

Publication number
ECSP034454A
ECSP034454A EC2003004454A ECSP034454A ECSP034454A EC SP034454 A ECSP034454 A EC SP034454A EC 2003004454 A EC2003004454 A EC 2003004454A EC SP034454 A ECSP034454 A EC SP034454A EC SP034454 A ECSP034454 A EC SP034454A
Authority
EC
Ecuador
Prior art keywords
crystal
therapeutic agent
pyridylsulfonyl
ethylpiperazine
polymorph
Prior art date
Application number
EC2003004454A
Other languages
English (en)
Inventor
Richard Anthony Storey
Albert Shaw Wood
Laurence James Harris
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0018656A external-priority patent/GB0018656D0/en
Priority claimed from GB0106464A external-priority patent/GB0106464D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of ECSP034454A publication Critical patent/ECSP034454A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

La presente invención proporciona un polimorfo de 1-{6-etoxi-5[etil-6, 7, -dihidro-2-(metoxietil)-7-oxo-2H-pirazol [4, 3-d]pirimidin-5-il]-3piridilsulfonil}-4-etilpiperazina.
EC2003004454A 2000-07-28 2003-01-28 Agente terapeutico cristalino ECSP034454A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0018656A GB0018656D0 (en) 2000-07-28 2000-07-28 Pharmaceutically active compounds
GB0106464A GB0106464D0 (en) 2001-03-15 2001-03-15 Crystalline therapeutic agent

Publications (1)

Publication Number Publication Date
ECSP034454A true ECSP034454A (es) 2003-03-10

Family

ID=26244756

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004454A ECSP034454A (es) 2000-07-28 2003-01-28 Agente terapeutico cristalino

Country Status (46)

Country Link
EP (1) EP1305314B1 (es)
JP (1) JP2004505087A (es)
KR (1) KR100457937B1 (es)
CN (1) CN1207297C (es)
AP (1) AP1400A (es)
AR (1) AR032628A1 (es)
AT (1) ATE286901T1 (es)
AU (2) AU7269001A (es)
BG (1) BG107266A (es)
BR (1) BR0112734A (es)
CA (1) CA2417264C (es)
CZ (1) CZ2003126A3 (es)
DE (1) DE60108398T2 (es)
DO (1) DOP2001000217A (es)
DZ (1) DZ3364A1 (es)
EA (1) EA004681B1 (es)
EC (1) ECSP034454A (es)
EE (1) EE200300045A (es)
ES (1) ES2231521T3 (es)
GE (1) GEP20053494B (es)
HK (1) HK1055954A1 (es)
HR (1) HRP20030061A2 (es)
HU (1) HUP0302982A3 (es)
IL (1) IL153226A0 (es)
IN (1) IN2002MU01649A (es)
IS (1) IS6626A (es)
MA (1) MA26931A1 (es)
MX (1) MX233602B (es)
MY (1) MY117831A (es)
NO (1) NO324220B1 (es)
NZ (1) NZ523226A (es)
OA (1) OA12337A (es)
PA (1) PA8523501A1 (es)
PE (1) PE20020277A1 (es)
PH (1) PH12001001922B1 (es)
PL (1) PL365133A1 (es)
PT (1) PT1305314E (es)
SK (1) SK572003A3 (es)
SV (1) SV2001000570A (es)
TN (1) TNSN01112A1 (es)
TW (1) TWI285643B (es)
UA (1) UA72631C2 (es)
UY (1) UY26854A1 (es)
WO (1) WO2002010171A1 (es)
YU (1) YU4703A (es)
ZA (1) ZA200301457B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004072079A1 (en) * 2003-02-11 2004-08-26 Pfizer Limited Hydrated and anhydrous sildenafil hemi-citrate compound
RS20050810A (en) 2003-04-29 2007-08-03 Pfizer Inc., 5,7-diaminopyrazolo(4,3-d)pyrimidines useful in the treatment of hypertension
US7572799B2 (en) 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
WO2005097799A1 (en) 2004-04-07 2005-10-20 Pfizer Limited Pyrazolo`4,3-d! pyrimidines
AU2006245416B2 (en) 2005-05-12 2012-02-23 Pfizer Inc. Anhydrous crystalline forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3721077B2 (ja) * 1998-04-20 2005-11-30 ファイザー・インク 性的不全を治療するためのピラゾロピリミジノンｃＧＭＰＰＤＥ５阻害剤
TWI265925B (en) * 1999-10-11 2006-11-11 Pfizer Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them

Also Published As

Publication number Publication date
NO20030416D0 (no) 2003-01-27
ATE286901T1 (de) 2005-01-15
WO2002010171A1 (en) 2002-02-07
AP2001002234A0 (en) 2001-09-30
MX233602B (es) 2006-01-10
KR100457937B1 (ko) 2004-11-20
UY26854A1 (es) 2002-02-28
YU4703A (sh) 2006-01-16
BR0112734A (pt) 2004-08-10
CN1444585A (zh) 2003-09-24
DZ3364A1 (fr) 2002-02-07
DE60108398D1 (de) 2005-02-17
ZA200301457B (en) 2004-04-28
IL153226A0 (en) 2003-07-06
DE60108398T2 (de) 2005-12-22
EP1305314B1 (en) 2005-01-12
AR032628A1 (es) 2003-11-19
NO20030416L (no) 2003-02-05
GEP20053494B (en) 2005-04-25
MXPA03000856A (es) 2003-06-06
AU7269001A (en) 2002-02-13
TWI285643B (en) 2007-08-21
MY117831A (en) 2004-08-30
JP2004505087A (ja) 2004-02-19
IN2002MU01649A (es) 2004-12-11
HUP0302982A3 (en) 2005-01-28
EA200300079A1 (ru) 2003-06-26
CA2417264C (en) 2007-06-12
HRP20030061A2 (en) 2003-04-30
CN1207297C (zh) 2005-06-22
DOP2001000217A (es) 2002-10-30
PT1305314E (pt) 2005-04-29
EA004681B1 (ru) 2004-06-24
SK572003A3 (en) 2004-05-04
CZ2003126A3 (cs) 2004-02-18
PH12001001922B1 (en) 2006-11-21
PL365133A1 (en) 2004-12-27
PA8523501A1 (es) 2002-10-24
TNSN01112A1 (fr) 2005-11-10
AP1400A (en) 2005-04-28
ES2231521T3 (es) 2005-05-16
PE20020277A1 (es) 2002-05-11
UA72631C2 (uk) 2005-03-15
EP1305314A1 (en) 2003-05-02
MA26931A1 (fr) 2004-12-20
HUP0302982A2 (hu) 2003-12-29
NZ523226A (en) 2003-07-25
EE200300045A (et) 2004-12-15
CA2417264A1 (en) 2002-02-07
KR20030016430A (ko) 2003-02-26
NO324220B1 (no) 2007-09-10
BG107266A (bg) 2003-07-31
OA12337A (en) 2006-05-15
AU2001272690B2 (en) 2005-12-08
SV2001000570A (es) 2002-09-03
HK1055954A1 (en) 2004-01-30
IS6626A (is) 2002-11-18

Similar Documents

Publication Publication Date Title
DE60112974D1 (en) Carbolinderivate
MXPA03006093A (es) Derivados de n(fenilsulfonil)glicina y su uso terapeutico.
MXPA03001431A (es) Polimeros de un analogo de epotilona.
EA200400481A1 (ru) Применение флибансерина для лечения половых расстройств
DE60216233D1 (en) Carbolinderivate
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
MXPA03006001A (es) Derivados de fosfonato de nucleosido aciclico novedoso, sales de estos y proceso para la preparacion de los mismos.
AU2002224927A1 (en) Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
EE9900539A (et) Uued ühendid
MXPA03002911A (es) Compuestos quimicos.
PL364598A1 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
MXPA02012076A (es) Compuestos quimicos.
AU2001266575A1 (en) Chemical compounds
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
WO2002070469A3 (en) Selective pde3b inhibitors and use of the same in therapy
ES2160410T3 (es) Preparados de complejos de protrombina inmunotolerantes.
WO2002030870A3 (de) Substituierte c-cyclohexylmethylamin-derivate
AU2002215904A1 (en) Compounds with a branched linker
AU2002213419A1 (en) Condensed pyridoindole derivatives
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
WO2001049654A3 (de) Substituierte aminomethyl-phenyl-cyclohexanderivate
ECSP034454A (es) Agente terapeutico cristalino
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
MXPA02012472A (es) Compuestos quimicos.